BioGaia sees sales grow 22%

16 Feb 2015

Probiotics company BioGaia has announced its full-year financial results. “A sales growth of 22% (including licence revenue from Nestlé 53 %) and an operating margin of 26% for the full year 2014, can only be summed up as a successful year,” said Peter Rothschild, CEO of BioGaia. “The fourth quarter showed even better growth than […]

BioGaia sees sales grow 22%

http://www.dreamstime.com/stock-photo-sales-growth-image20577300Probiotics company BioGaia has announced its full-year financial results.

“A sales growth of 22% (including licence revenue from Nestlé 53 %) and an operating margin of 26% for the full year 2014, can only be summed up as a successful year,” said Peter Rothschild, CEO of BioGaia. “The fourth quarter showed even better growth than the full year and it is once again gratifying to see that almost all of our markets are growing at a solid pace and that the BioGaia brand is becoming increasingly established, particularly among paediatricians, as the safest and most effective probiotic on the market.”

Full year 2014
(Figures in brackets refer to the same period of last year)

  • Net sales amounted to SEK 481.8 million (315.9), an increase of SEK 165.9 million (53 %). Net sales include license revenue of SEK 95.4 million from Nestlé. Excluding license revenue from Nestlé, net sales totalled SEK 386.4 million, an increase of 22% (excluding foreign exchange effects, 18%).
  • Net sales in the Paediatrics Business Unit reached SEK 313.7¹ million (238.6), up by SEK 75.1 million (31%).
  • Net sales in the Adult Health Business Unit amounted to SEK 69.4 million (75.6), a decrease of SEK 6.2 million (-8%).
  • Operating profit was SEK 196.9 million (81.7), an increase of SEK 115.2 million (141%). Excluding license revenue from Nestlé, operating profit was SEK 101.5 million, an increase of 24% (excluding foreign exchange effects and operating expenses for the subsidiary IBT, 21%).
  • Profit after tax was SEK 148.0 million (64.2), up by SEK 83.8 million (130%). Excluding license revenue from Nestlé, profit after tax was SEK 73.6 million, an increase of 15%.

Fourth quarter 2014

  • Net sales reached SEK 121.4 million (90.2), an increase of SEK 31.2 million (35%) (excluding foreign exchange effects, 28%).
  • Net sales in the Paediatrics Business Unit totalled SEK 97.8 million (65.6), an improvement of SEK 32.2 million (49%).
  • Net sales in the Adult Health Business Unit amounted to SEK 23.0 million (24.1), a decrease of SEK 1.1 million (-4%).
  • Operating profit was SEK 30.6 million (23.8), an increase of SEK 6.8 million (29 %) (excluding foreign exchange effects and operating expenses for the subsidiary IBT, 23%).
  • Profit after tax was SEK 19.1 million (16.3), an improvement of SEK 2.8 million (17%).

 

 

Related tags

New

Related news

Glanbia announces performance nutrition ingredients

Glanbia announces performance nutrition ingredients

25 May 2018

Glanbia Nutritionals has announced what it describes as two new pioneering and innovative performance nutrition ingredients for formulation in functional beverages in Europe, the Middle East and Africa.

Read more 
Ecotrophelia UK shortlist announced

Ecotrophelia UK shortlist announced

24 May 2018

The growing trend for plant-based diets has inspired the teams that have entered this year’s student food innovation competition – Ecotrophelia UK. All five of the shortlisted products are meat-free and four are also vegan.

Read more 
Healthcare continuum drives Lonza growth

Healthcare continuum drives Lonza growth

10 May 2018

Lonza has reported what it describes as a positive start to 2018 with businesses along the healthcare continuum as growth drivers.

Read more 
Arla enters breakfast food-to-go market

Arla enters breakfast food-to-go market

9 May 2018

Arla Foods is set to launch into the breakfast food-to-go market with the introduction of its new Milk & Oats range of ready to drink beverages.

Read more 
Eurofins to acquire Covance Food Solutions

Eurofins to acquire Covance Food Solutions

7 May 2018

Global life sciences company LabCorp has announced that it has entered into a definitive agreement under which Eurofins Scientific will acquire the Covance Food Solutions business from LabCorp for $670 million.

Read more 
Engaging with the Instagram generation

Engaging with the Instagram generation

3 May 2018

Colourful, exotic and unusual foods are on the rise as a growing number of consumers look for food experiences they can share on social media.

Read more 
New shake makes children taller

New shake makes children taller

1 May 2018

Nutritional Growth Solutions is introducing Healthy Height, a kids’ protein shake the company says is clinically shown to improve children’s height, to the European market.

Read more 
Mintel: Europe leads on private label launches

Mintel: Europe leads on private label launches

27 Apr 2018

Europe accounted for over half (57%) of all private label launches with premium claims globally in 2017, according to new research from Mintel Global New Products Database (GNPD).

Read more 
Ohly launches maple syrup powder

Ohly launches maple syrup powder

1 Aug 2016

Ohly has launched a new Maple Syrup Specialty Powder. The latest addition to the ProDry range is said to deliver authentic maple syrup flavour and sweetness in a free flowing powder form.

Read more 
Welch's extends FruitWorx

Welch's extends FruitWorx

8 Jul 2016

Welch’s Global Ingredients Group has launched FruitWorx Concord Grape Juice Powder, extending a range that already includes a range of Concord and Niagara grape-based fruit pieces, flakes and pastes.

Read more